Hemifacial Spasm Clinical Presentation
- Author: Steven Gulevich, MD; Chief Editor: Nicholas Lorenzo, MD more...
History
Involuntary facial movement is the only symptom. Fatigue, anxiety, or reading may precipitate the movements.
- Hemimasticatory spasm
- Hemimasticatory spasm is analogous to hemifacial spasm and occurs with irritation to the motor trigeminal nerve.
- This rare condition is a segmental myoclonus and presents with unilateral involuntary contractions of the trigeminally innervated muscles of mastication (usually the masseter).
- Similar to hemifacial spasm, hemimasticatory spasm responds to treatment with medications and botulinum toxin.
- However, less evidence exists that exploratory surgery benefits patients with this condition.
- Myoclonic movements
- Myoclonic movements affecting facial musculature also may arise from lesions at the brain or brainstem level.
- These are distinguished from hemifacial spasm by the distribution of abnormal movements (more generalized, possibly bilateral) and possibly by electrodiagnostic evaluation.
- Imaging studies may yield an underlying cause.
- Central myoclonus responds to anticonvulsant management.
- Oromandibular dystonia
- Oromandibular dystonia (OMD) refers to dystonia affecting the lower facial musculature, predominantly the jaw, pharynx, and tongue.
- When oromandibular dystonia occurs in conjunction with blepharospasm, the disorder is termed Meige syndrome.
- Jaw-opening forms of oromandibular dystonia indicate primary involvement of the digastric and lateral pterygoid. Jaw-closing oromandibular dystonia involves the masseter, temporalis, and medial pterygoid.
- Jaw deviation, indicating predominant involvement of the lateral pterygoid, is rare.
- Botulinum toxin is the preferred treatment for oromandibular dystonia and is most effective in the jaw-closure type.
- Medications seldom yield acceptable results. When medications must be used, employ the same agents as for blepharospasm.
- Because of the risk of aspiration, never inject botulinum toxin into the tongue.
- Craniofacial tremor
- Craniofacial tremor may occur in association with essential tremor, Parkinson disease, thyroid dysfunction, or electrolyte disturbance.
- It occurs rarely in isolation.
- Focal motor seizures must occasionally be distinguished from other facial movement disorders, particularly hemifacial spasm.
- Postictal weakness and greater involvement of the lower face are distinguishing features of focal motor seizures.
- Facial chorea
- Facial chorea occurs in the context of a systemic movement disorder (eg, Huntington disease, Sydenham chorea).
- Chorea is a random, flowing, nonpatterned set of movements.
- A related disorder, spontaneous orofacial dyskinesia of the elderly, is observed primarily in the edentulous. It usually responds to proper fitting of dentures.
- Tics
- Facial tics are brief, repetitive, coordinated, semipurposeful movements of grouped facial and neck muscles.
- Tics may occur physiologically or in association with diffuse encephalopathy.
- Some medications (ie, anticonvulsants, caffeine, methylphenidate, antiparkinsonian agents) are associated with producing tics.
- Single, repetitive, stereotyped movements (eg, repetitive grimacing, throat clearing, vocalizations) define a simple tic disorder.
- Facial myokymia
- Facial myokymia appears as vermicular twitching under the skin, often with a wavelike spread.
- This is distinguished from other abnormal facial movements by characteristic electromyogram discharges presenting as brief, repetitive bursts of motor unit potentials firing at 2-60 Hz interrupted by periods of silence of up to a few seconds.
- Facial myokymia may occur with any brainstem process. Severe cases may benefit from botulinum toxin.
- Most cases are idiopathic and resolve without treatment over several weeks.
Physical
- The only physical finding in hemifacial spasm is involuntary facial movements.
- Spontaneous hemifacial spasm manifests with facial spasms that represent myoclonic jerks and are analogous to segmental myoclonus, which may affect other body regions.
- Postparalytic hemifacial spasm (following facial nerve trauma such as Bell palsy) manifests as facial synkinesis and contracture.
Causes
- Idiopathic
- Vascular compression
- Facial nerve compression by mass
- Brainstem lesion such as stroke or multiple sclerosis plaque
- Secondary to trauma or Bell palsy
Mauriello JA, Leone T, Dhillon S, et al. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg. Aug 1996;98(3):213-6. [Medline].
Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. Aug 1990;53(8):633-9. [Medline].
Colosimo C, Chianese M, Giovannelli M, et al. Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neurol Neurosurg Psychiatry. May 2003;74(5):687. [Medline].
Adler CH, Zimmerman RA, Savino PJ, et al. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol. Oct 1992;32(4):502-6. [Medline].
Campos-Benitez M, Kaufmann AM. Neurovascular compression findings in hemifacial spasm. J Neurosurg. Sep 2008;109(3):416-20. [Medline].
Cruccu G, Inghilleri M, Berardelli A, et al. Pathophysiology of hemimasticatory spasm. J Neurol Neurosurg Psychiatry. Jan 1994;57(1):43-50. [Medline].
Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol. Jan 1992;239(1):5-8. [Medline].
Jannetta PJ, Abbasy M, Maroon JC, et al. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg. Sep 1977;47(3):321-8. [Medline].
Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. CMAJ. Nov 1 1988;139(9):837-44. [Medline].
Moller AR. The cranial nerve vascular compression syndrome: I. A review of treatment. Acta Neurochir (Wien). 1991;113(1-2):18-23. [Medline].
Moller AR. The cranial nerve vascular compression syndrome: II. A review of pathophysiology. Acta Neurochir (Wien). 1991;113(1-2):24-30. [Medline].
Reimer J, Gilg K, Karow A, et al. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand. Jan 2005;111(1):64-70. [Medline].

